Free Trial

Repare Therapeutics (RPTX) SEC Filings & 10K Form

Repare Therapeutics logo
$2.84 -0.04 (-1.39%)
(As of 11/20/2024 ET)

Recent Repare Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:42 AM
Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
11/07/2024
7:33 AM
Repare Therapeutics (Filer)
Form 424B5
11/07/2024
6:10 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:15 AM
Repare Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
11:15 PM
Repare Therapeutics (Filer)
Form EFFECT
08/07/2024
8:06 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:41 PM
Repare Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2024
3:20 PM
Repare Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2024
3:27 PM
Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/20/2024
3:36 PM
Repare Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Repare Therapeutics (Issuer)
Stein Steven H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Civik Thomas (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Bonita David P (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Kulkarni Samarth (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Molineaux Susan (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Morrison Briggs (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:35 PM
Repare Therapeutics (Issuer)
RHOADS ANN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
3:06 PM
Repare Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/26/2024
3:14 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
8:27 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:28 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:30 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
8:31 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:54 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:56 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:57 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
5:59 PM
Forte Steve (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
11:37 AM
Forte Steve (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
1:50 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
6:25 PM
Repare Therapeutics (Subject)
Segal Lloyd Mitchell (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Koehler Maria (Reporting)
Repare Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:23 PM
Repare Therapeutics (Subject)
Zinda Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
8:02 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:04 PM
Repare Therapeutics (Issuer)
Segal Lloyd Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:06 PM
Repare Therapeutics (Issuer)
Zinda Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:10 AM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:15 AM
Repare Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
8:02 PM
Blue Owl Capital Holdings LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G
02/14/2024
7:54 AM
Deep Track Capital, LP (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
01/29/2024
3:01 PM
ARK Investment Management LLC (Filed by)
Repare Therapeutics (Subject)
Form SC 13G/A
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
01/25/2024
1:29 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:05 PM
Repare Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:19 PM
Koehler Maria (Reporting)
Repare Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RPTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners